AngioDynamics Reports Fiscal 2020 First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
AngioDynamics (ANGO) Tops Q1 EPS by 4c, Revenues Miss; Offers FY20 EPS Guidance Below Consensus, FY20 Mid-Point Revenue View Above Consensus
October 3, 2019 6:05 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q1 EPS of $0.08, $0.04 better than the analyst estimate of $0.04. Revenue for the quarter came in at $66 million versus the consensus estimate of $67.52 million.
Fiscal 2020 First Quarter Highlights
Net sales of $66.0 million, an increase of 3.3% year over yearGross margin increased 170 basis points year over year to 57.9%GAAP loss per share of $0.03; adjusted earnings per... More